INTRODUCTION
Despite their widespread use in fertility control and gynaecological disorders, the exact mode of action of synthetic progestagens remains obscure. Although it is likely that the total effectiveness of these agents probably results from their action at multiple sites in the body (such as the ovary, uterine tubes, uterus, cervix, pituitary and hypothalamus), their primary action is believed to be exerted at the pituitary-hypothalamic level, inhibiting the output of luteinizing hormone (lh) and consequently ovulation (Vorys, Ullery & Stevens, 1965; Flowers, Vorys, Stevens, Miller & Jensen, 1966) .
Previously it has been reported that prolonged administration of a progesterone derivative, Provera, results in depletion of pituitary lh stores (Labhsetwar, 1966b) , while the administration of a 19-nor steroid derivative, norethynodrel, for a period of 10 or less days was found to result in a significant increase in the pituitary lh content of the female (Labhsetwar, 1967b) as well as the male rat (Brown, Wells & Youngson, 1965) .
In the present study one of the most potent derivatives of progesterone, chlormadinone (6-chloro-A6-17a-acetoxyprogesterone), was employed. It is estimated to be 3500 times more active than norethisterone, both in the Clauberg assay and anti-ovulatory test in the rabbit (Rudel & Kind, 1966) . As little as 0-5 mg of the compound taken orally without oestrogen has been reported to exert a contraceptive effect in women (Martinez-Manautou, Cortez, Giner, Aznar, Casasola & Rudel, 1966) . It exhibits a very mild anti-gonadotrophic activity in parabiotic rats (Brennan & Kray, 1963) and has been found virtually free from virilizing and androgenic proper¬ ties (see Rudel & Kind, 1966) . Additionally it is a true progestagen in the sense that it can maintain pregnancy in spayed rats (Labhsetwar, 1967c) used, a symmetrical four-point design with two doses of standard lh (0-8/tg and 4 µg of nih-lh-s-11) and two doses of pituitary tissue (0-4 mg and 2 mg) was employed. In the bilaterally spayed rats the doses of the pituitary glands were reduced by half. Initially one ovary was used and the second ovary was used 48 hr later. Four or five assay rats/dose were employed. The assay statistics (relative potency, confidence limits, index of precision, etc.) were calculated according to the method described by Gaddum (1953) for parallel line assays. The mean index of precision { ) for ten determinations was 0-251+0-05 (s.e.).
Bio-assay for FSH
A slight modification (Labhsetwar, 1967c) 
RESULTS

Body weight
Administration of chlormadinone to rats with one or both ovaries resulted in a significant increase in body weight (P<0-05, Table 2 ). The mean daily body weight gain in three groups of adult treated rats (two intact and one unilaterally spayed) was significantly higher than a similar mean for three corresponding control groups (2-70 + 0-03 g versus 1-33 + 0-18 g, P<0-01). Bilateral ovariec¬ tomy itself significantly increased the body-weight gain ; chlormadinone failed to augment this weight gain, either in adult or immature rats (Table 2) .
Organ weights
The chlormadinone administration resulted in a significant atrophy of the pituitary glands, ovaries and adrenals in the intact and unilaterally spayed rats, both on a relative (mg/100 g body wt, Table 2 ) and an absolute (mg/rat, Tables 3 and 4) body weight basis. In the adult rats, bilateral ovariectomy itself reduced the pituitary and adrenal weights significantly when compared with the intact controls (Table 2) ; chlormadinone in these rats further reduced the adrenal but not the pituitary weights (P<0-01, Table 2 ).
In the intact and unilaterally spayed rats treated with chlormadinone, the relative uterine weights were consistently and sometimes significantly (P<0-05) lower than those of the respective controls. In contrast, in the bilaterally spayed adult as well as immature rats treated with progestagen, uterine weights were significantly higher than those of the respective controls (P<0-05, Table  2 ), confirming the previous report (Harper, 1964) . At autopsy none of the treated rats with one or both ovaries revealed ballooned uteri, while in the control groups (except in Exp. 3) some of the animals showed this condition.
Ovarian histology
Paraffin sections (7 µ) were stained either with haematoxylin-eosin or a tetrachrome method, which selectively stains collagen. The corpora lutea in the treated animals, although fewer in number, appeared healthy and contained fewer connective tissue elements than the controls. Vesicular follicles of varying sizes, up to but not including pre-ovulatory size, were present in the ovaries of the treated animals, but most of them appeared atretic. The interstitial tissue in the ovaries of the treated animals also appeared atrophie.
Ovarian compensatory hypertrophy
Progestagen treatment resulted in inhibition of ovarian compensatory hyper¬ trophy in all experiments (Table 3) , and prevented the compensatory increase in the number of corpora lutea usually seen in the unilaterally spayed rats (Table 3) (Table 4) , confirming the previous reports (Edgren, Parlow, Peterson & Jones, 1965; Labhsetwar, 1967c) . In contrast, the removal of both ovaries resulted in a several-fold increase in the pituitary stores of both gonadotrophins (Table 4) .
Administration of chlormadinone to intact and unilaterally spayed rats resulted in marked increases (>100%) in the concentration (/<g/mg) and the total content (/ig/pituitary) of both lh and fsh (Table 3 ). The gonadotrophin content (^g/gland) increased, despite a significant atrophy of the pituitary gland both on a relative (Table 2) and an absolute basis (Table 4) In the bilaterally spayed adult and immature rats, progestagen treatment did not alter the ovariectomy-induced rise in the pituitary stores of either lh or fsh (Table 4) .
FSHILH ratio
The ratio of fsh concentration (jug/mg) to that of lh was always in favour of fsh in both the control and the treated animals. The removal of one or both ovaries or administration of chlormadinone did not materially affect the ratio (Table 4) .
as S3
•5. 
DISCUSSION
The data suggest that chlormadinone administration results in increased pituit¬ ary stores of fsh and lh. A significant atrophy of the ovaries in the intact treated rats (Table 2) , together with an inhibition of ovarian compensatory hyper¬ trophy (Table 3) , a lack of compensatory increase in the number of corpora lutea in the unilaterally spayed rats (Table 3 ) and the atrophy of the interstitial tissue of the ovary indicate either a decline in the output of fsh and lh, or a decrease in the ovarian sensitivity to these hormones. However, ovaries of immature pseudopregnant rats treated with this progestagen were as sensitive to the ovarian-ascorbic-acid-depleting activity of exogenous lh as those of the controls. Furthermore, ovaries in rats (Harper, 1964) and rabbits (Rudel & Kind, 1966) Labhsetwar, 1967a; Schwartz & Rothchild, 1964) , while progesterone (Everett, 1964) as well as synthetic progestagen-norethynodrel (Labhsetwar, 1966a) have been found capable of inducing pseudopregnancy in the rat.
It seems that inhibition of lh release by chlormadinone is partial, involving only the ovulatory surge of the hormone. The presence of vesicular follicles of varying sizes in the ovaries of the treated animals indicates that gonadotrophins (particularly fsh) adequate to support follicular growth were being secreted in the presence of chlormadinone. These follicles probably secrete oestrogens, since significant uterine atrophy did not always result after administration of chlormadinone to animals with one or both ovaries. Alternatively, the utero¬ trophic action of the agent may have overcome the oestrogen deficiency result¬ ing from reduction in lh output. The uterotrophic property of this agent was evident in the absence of both ovaries (Table 2) .
Two important properties of this compound observed in this study, are its ability to (i) increase body weight, and (ii) cause an atrophy of the pituitary gland, both on an absolute and a relative basis, in intact and unilaterally spayed rats. Since both of these effects were absent in the bilaterally spayed rats, they appear to be mediated through the ovary and most probably result from neutralization of effects of endogenous oestrogens by chlormadinone. The anti-oestrogenic property of this compound is well documented . In contrast, the adrenolytic effect of chlormadinone appears to be independent of the ovaries (Table 2) .
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